Meager 2019 - Bayesian Hierarchical Analysis of Microcredit - Overview

Summary

Meager (AEJ: Applied 2019) aggregates seven randomised microcredit trials with Bayesian hierarchical models that jointly estimate the average effect and the cross-site heterogeneity . Average effects on business and consumption outcomes are small (about 5% of the control mean) and uncertain; about 60% of observed heterogeneity is sampling variation, so the trials are reasonably externally valid; and economic features (interest rates, loan size, women-targeting) predict effects better than study protocols.

Overview

Research question. Multiple RCTs of microcredit exist, but consensus on the overall result has been impeded by external-validity concerns: the studies may be too different from each other and from future settings to permit general conclusions. How large is the average effect, and how heterogeneous are effects across sites?

Approach. Rubin (1981)-style hierarchical models (and richer full-data versions with control means, household covariates and site covariates) estimated by Hamiltonian Monte Carlo in Stan, compared with classical full-pooling OLS and “vote-counting”. Heterogeneity is assessed through , the posterior predictive distribution for the next site, and three pooling metrics.

Key results.

  • Posterior mean effects (USD PPP per fortnight): profit , expenditures , revenues , consumption , consumer durables , temptation goods ; all 95% intervals include zero (Table 2).
  • “Statistical significance” under full-pooling OLS for revenues and temptation goods disappears under the hierarchical model.
  • Average pooling across all metrics and outcomes sampling variation; no pooling of control means.
  • Predictive intervals for the next site are far wider than OLS (about three times for profit) and for almost all outcomes have a 25% chance of an adverse sign.
  • Prior business experience: precise zero profit effect without it; larger but more heterogeneous with it.
  • Ridge regression on seven sites: women-targeting, interest rate, loan size more predictive than randomisation unit.

Main Content

Source Map

Paper sectionWhere covered
Abstract; Introduction (pp. 57-60)this note; Meager 2019 - Studies, Data and Outcomes (literature and inclusion)
I. Data (Table 1)Meager 2019 - Studies, Data and Outcomes
II.A Hierarchical models, eq. 1-4, exchangeabilityMeager 2019 - Hierarchical Model Specifications
II.B Bayesian estimation and inference, priors (eq. 5)Meager 2019 - Bayesian Estimation, Priors and Computation
II.C Measuring external validity; eq. 6-8Meager 2019 - Pooling Factors and Measuring External Validity
III. General impact (Table 2, Fig 1-4)Meager 2019 - Average Treatment Effects - Results
IV. Heterogeneity (Tables 3-4, Figs 5-6)Meager 2019 - Heterogeneity, Pooling Results and Predictive Distributions
V.A Household covariates (Figs 7-9); V.B Site-level covariates (Table 5, Fig 10)Meager 2019 - Covariates - Prior Business Experience and Site-Level Ridge
VI. ConclusionMeager 2019 - Conclusion, Limitations and Marketing Analogues
Appendix A: technical details of estimation (HMC, NUTS, )Meager 2019 - Bayesian Estimation, Priors and Computation
Online appendices B, C (robustness, cross-validation)referenced only; not in the PDF

Notation

sites indexed by ; site-specific average treatment effect; and its estimate and standard error; the general effect; cross-site heterogeneity; control-group mean; outcome of household in site ; treatment indicator; the effect in a new, exchangeable site.

Examples

See Table 2 and the profit example in Meager 2019 - Average Treatment Effects - Results, and a runnable Rubin-model illustration (hypothetical data) in Meager 2019 - Pooling Factors and Measuring External Validity.

Connections

Relevance to marketing measurement

The setup is the same as combining many geo or conversion-lift experiments for a channel: site experiment/market, the channel’s general lift, how portable it is, the lift you should expect in the next flight. See the marketing-focused section in Meager 2019 - Conclusion, Limitations and Marketing Analogues (extension is mine, not the paper’s).

See Also